跳至主要内容
临床试验/NCT03737045
NCT03737045已完成不适用

Developing a Patient-centered Patient Decision Aid for Psoriasis and/or Psoriatic Arthritis Using Design Thinking.

University of Pennsylvania1 个研究点 分布在 1 个国家目标入组 37 人开始时间: 2018年12月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
37
试验地点
1
主要终点
Patient and provider self-reported perceptions of the decision aid as measured by satisfaction survey

研究概览

简要总结

The purpose of this study is to create and test a patient decision aid that facilitates the shared decision-making process when patients with psoriasis and/or psoriatic arthritis are starting or switching to a new therapy.

详细描述

Prior to the interventional study, we will develop a decision aid using design thinking. In this interventional study, we will implement and test a patient-centered decision aid for therapy selection among patients with psoriasis and/or psoriatic arthritis who are starting or switching to a new medication.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

盲法说明

Participants will have a choice of decision aids (web or paper) and will not be blinded. The study team will be aware of each prototype and decision aid that participants use.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 years or older
  • Diagnosis of psoriasis (as confirmed by dermatologist) or psoriatic arthritis (as confirmed by rheumatologist)
  • Treated at Penn
  • In addition to the above, for the observation and implementation phases of the study:
  • Initiation of a new psoriasis or psoriatic arthritis treatment
  • Biosimilars that have been approved by the FDA and available on the US market will similarly be eligible for participation
  • Patients may be taking other traditional DMARDs.
  • A washout period is not required.

排除标准

  • Unable to give informed consent
  • Youth, under the age of 18 years
  • Patients without psoriasis or psoriatic arthritis
  • Not being treated at a Penn clinic
  • In addition to the above, for the observation and implementation phases of the study:
  • Not starting or switching to a new medication

研究组 & 干预措施

Decision Aid Testing

Other

Participants will have the opportunity to test the different decision aid prototypes while selecting new treatment/therapy.

干预措施: Decision Aid (Other)

结局指标

主要结局

Patient and provider self-reported perceptions of the decision aid as measured by satisfaction survey

时间窗: Up to 24 months

Satisfaction survey to rate the decision aid and shared decision-making process

次要结局

  • Number of times decision aid was used in consultation for patients switching therapies or starting a new treatment.(Up to 24 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验